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Beyond iron: non-classical biological functions of
bacterial siderophores
Timothy C. Johnstone and Elizabeth M. Nolan*
Bacteria secrete small molecules known as siderophores to acquire iron from their surroundings. For over
60 years, investigations into the bioinorganic chemistry of these molecules, including fundamental
coordination chemistry studies, have provided insight into the crucial role that siderophores play in bac-
terial iron homeostasis. The importance of understanding the fundamental chemistry underlying bacterial
life has been highlighted evermore in recent years because of the emergence of antibiotic-resistant bac-
teria and the need to prevent the global rise of these superbugs. Increasing reports of siderophores func-
tioning in capacities other than iron transport have appeared recently, but reports of “non-classical”
siderophore functions have long paralleled those of iron transport. One particular non-classical function
of these iron chelators, namely antibiotic activity, was documented before the role of siderophores in iron
transport was established. In this Perspective, we present an exposition of past and current work into
non-classical functions of siderophores and highlight the directions in which we anticipate that this
research is headed. Examples include the ability of siderophores to function as zincophores, chalko-
phores, and metallophores for a variety of other metals, sequester heavy metal toxins, transport boron,
act as signalling molecules, regulate oxidative stress, and provide antibacterial activity.
Introduction
Iron is an essential nutrient for nearly all known life forms.
The caveat is included in the preceding statement because
certain lactobacilli and the causative agent of Lyme disease,
Borrelia burgdorferi, do not require iron for growth.1,2 Iron is
commonly used in biological systems most likely because of
its Earth abundance and the breadth of the chemistry that it
can undergo.3 This element exists in two readily inter-converti-
ble oxidation states: ferrous and ferric, or Fe(II) and Fe(III),
respectively. The ability to convert between these two states
allows iron to play a pivotal role in numerous electron transfer
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processes.4 The precisely tuned steric and electronic environ-
ments within enzyme active sites permit access to more highly
oxidized, Fe(IV) and Fe(V), or reduced, Fe(I), states that are
essential intermediates in catalytic biochemical transform-
ations that range from methane oxidation to proton
reduction.5,6 Moreover, iron centres can access diﬀerent spin
states, which allows chemical reactions to occur at this metal
centre that are not as readily feasible in purely organic
systems.7,8 Despite the ubiquity of iron in biology, the very
nature of its aqueous chemistry dictates that, under aerobic
conditions and at neutral pH, the concentration of dissolved
iron is lower than the concentration needed to sustain bac-
terial life.9 In this regard, and in the discussions below, dis-
solved or soluble iron refers to solvated aquo/hydroxo
complexes of the metal.
The solubility of Fe(III) in water at neutral pH is typically
quoted to be 10−18 M,10,11 a value derived from the solubility
product of Fe(OH)3, Ksp ≈ 10−39,12 and the concentration of
hydroxide at neutral pH, [OH] = 10−7 M. An alternative soluble
Fe(III) concentration of 1.4 nM has been proposed on theore-
tical grounds following re-evaluation of the importance of
Fe(OH)2
+ (aq.) in the speciation of this element.13,14 Regardless
of this correction, the concentration of Fe(III) in solution falls
far below the level to which iron is concentrated within bac-
teria. For instance, spectrochemical analysis revealed the dry
weight of Escherichia coli to be 0.021% Fe.15 A cell volume of
10−15 L16,17 and a dry mass of 10−13 g17 aﬀords a whole cell
concentration of Fe that is approximately 10−3 M. This concen-
tration deviates from the value previously quoted (10−6 M);11
however, a comparison of either value to the solubility of Fe(III)
highlights the extent to which bacteria concentrate Fe obtained
from the environment. For commensal and pathogenic bac-
teria that colonize humans, iron concentrations are even more
limited. The low levels of Fe(III) that exist freely in solution are
toxic to mammals and are accordingly suppressed by a
number of mechanisms. Most notably, Fe(III) levels in human
serum are maintained at approximately 10−24 M by transfer-
rin,18 an abundant iron transport protein. We note that this
concentration of Fe(III) in serum is obtained by using the trans-
ferrin log K1 = 22.7, log K2 = 22.1, and the estimation that at
any given time about 30% of the binding sites of transferrin in
blood are empty.18
In order to acquire iron under these conditions, bacteria
employ a number of transport mechanisms.10 One of the most
striking is the secretion of siderophores, small molecules that
exhibit high binding aﬃnity for iron.19 A similar strategy is
employed by fungi20 and plants21 but the focus of this Perspec-
tive will be on bacterial siderophores. These chelators exhibit
proton-independent stability constants (β) for iron complexa-
tion ranging from approximately 1010 to 1049.22,23 The latter is
the β110 value for the complex of Fe(III) and enterobactin
6−,
where the βMLH notation indicates the formation constant for a
given stoichiometry of metal (M), fully deprotonated ligand
(L), and protons (H). Although the β values of diﬀerent sidero-
phores may not be directly comparable because of diﬀerences
in ligand pKa values and metal : ligand binding ratios, entero-
bactin is widely credited as the siderophore with the highest
known aﬃnity for iron.24 This statement is borne out by
Chart 1 Chemical structures of the siderophores discussed in the introduction. The stereochemistry of yersiniabactin was taken from ref. 31. The
structure of salmochelin S2 is that reported in ref. 32. An alternative structure of a linearized salmochelin S4 in which a glucosyl unit is attached at
the carboxylic acid end of the linearized trimer instead of the alcohol end has also been reported.33 The enantiomer of the form of pyochelin
shown, enantio-pyochelin, is a known siderophore. ‡Many pyoverdines exist and are distinguished by the nature of the peptide chain attached at the
R position.
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metrics, such as pFe(III),† which more accurately compare the
stabilities of Fe(III) complexes under physiologically relevant
conditions.24 The enormous range in stability constants
reflects the diversity of chemical composition across the >260
siderophores of known chemical structure.25,26 The chemical
structures of the siderophores discussed in this paper are col-
lected in Charts 1–9. The chemical structures and stereochemi-
cal assignments are in general agreement with those given in a
recent comprehensive review of the siderophore literature,26
and when diﬀerences occur they are noted in the
Chart captions. Table 1 lists all of the siderophores discussed
in this Perspective in alphabetical order, provides the locations
of the corresponding chemical structures, and summarizes the
non-classical functions of each.
The typical metal-binding motifs – catecholates, hydroxa-
mates, and α-hydroxycarboxylic acids – select for Fe(III) in
accordance with the hard-soft acid–base theory. These hard
oxygen-atom donors are well-matched to the hard ferric ion.
Many siderophores present six coordinating atoms to the
metal centre in a pseudooctahedral geometry and a number of
these ligands exhibit a metal-binding pocket that is preorga-
nized, typically via macrocyclization. For example, the linear
dihydroxybenzoylserine trimer, a product of the hydrolysis of
enterobactin, exhibits a proton-independent formation con-
stant of 1043, as compared to the cyclized parent compound,
which exhibited a corresponding β value of 1049.27 Addition-
ally, the macrocyclic dihydroxamate siderophore alcaligin
binds Fe(III) 32 times more strongly than the linear dihydroxa-
mate rhodotorulic acid, as determined by comparing the
proton-independent stability constants of the 1 : 1 Fe–sidero-
phore complexes.28 In addition to macrocyclization, another
general strategy employed in siderophore biosynthesis is het-
erocyclization, exemplified by the enzyme-catalyzed cyclodehy-
Table 1 Putative non-classical biological functions of the bacterial siderophores discussed in this Perspective
Siderophore Non-classical function(s) Chart(s) containing structure
Aerobactin — 6
Alcaligin Cell signalling 1, 6
Aminochelin Mo/V transport 3
Azotobactin Mo/V transport 3
Azotochelin Mo/V transport 3
Citrate — 1
Coelibactin Zn binding 2
Coelichelin Zn binding 2
Coprogen — 1
Danoxamine Antibiotic component 7
Delftibactins (A, B) Other non-iron metallophore 5
(Des)ferrioxamine B Other non-iron metallophore 5
(Des)ferrioxamine E Other non-iron metallophore 5
2,3-Dihydroxybenzoylserine Cell signalling 6
Enterobactin Cell signalling 1, 4, 6, 7
Oxidative stress response
Ferrichrome Antibiotic component 7
Micacocidin Zn binding 2
Protochelin Mo/V transport 3
Other non-iron metallophore
Pyochelin Cu binding 1, 4
Other non-iron metallophore
Antibiotic activity
Pyoverdines Zn binding 1, 2, 4, 6, 7
Cu binding
Other non-iron metallophore
Cell signalling
Pyridine-2,6-dithiocarboxylate (pdtc) Zn binding 2, 4
Cu binding
Other non-iron metallophore
Rhizoferrin Zn binding 2
Rhodotorulic acid — 1
Salmochelins (S2, S4) Oxidative stress response 1, 7
Schizokinen Cu binding 4
Other non-iron metallophore
Staphyloferrin A Oxidative stress response 7
Staphyloferrin B Oxidative stress response 7
Vibrioferrin Boron transport 5, 6
Cell signalling
Yersiniabactin Zn binding 1, 2, 4, 6
Cu binding
Cell signalling
Oxidative stress response
†The pFe(III) is the negative of the decadic logarithm of the concentration of free
Fe(III) in solution under the following fixed conditions: pH = 7.4, total ligand
concentration = 10 μM, and total Fe(III) concentration = 1 μM.
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dration of X-cysteine and X-serine dipeptide motifs to form thi-
azoline and oxazoline rings, respectively.29 These heterocycles
can undergo further modifications, including dehydration and
aromatization to aﬀord thiazoles and oxazoles, or reduction to
aﬀord thiazolidines and oxazolidines. Such chemistry, used in
the biosynthesis of siderophores such as yersiniabactin and
pyochelin, rigidifies the peptide backbone and increases the
basicity of the formerly peptidic nitrogen atom, allowing it to
better coordinate iron.30
Many bacteria produce, or are capable of utilizing, multiple
siderophores. For instance, the laboratory strain E. coli K-12
expresses machinery for the uptake of ferric complexes of
enterobactin, linearized enterobactin, citrate, ferrichrome, rho-
dotorulate, and coprogen.24 E. coli K-12 cannot produce the
latter three siderophores, however.34 Siderophores used by a
non-producer organism are called xenosiderophores. The FoxA-
mediated uptake of ferrioxamine by Yersinia enterocolitica and
the uptake of enterobactin via Pseudomonas aeruginosa PfeA
and PirA are further examples of xenosiderophore
utilization.35–37 The ability of organisms to use redundant
siderophore-meditated iron uptake pathways has prompted
the question as to why such overlap exists.
One answer to this question is that diﬀerent siderophores
can better extract iron from diﬀerent sources or under
diﬀerent environmental conditions.38–40 Additionally, certain
siderophores permit bacterial pathogens to better evade the
host immune system. For example, Salmonella enterica
produce enterobactin to satisfy their nutritional requirements,
but humans have evolved a defence mechanism whereby the
secreted host-defence protein lipocalin-2 binds and sequesters
ferric enterobactin. In response, Salmonella produce sal-
mochelins,41 enterobactin derivatives that are glucosylated at
the C5 position of one or more catechol rings to prevent
capture by lipocalin-2.42 Certain pathogenic E. coli also
produce salmochelins to overcome the host response to infec-
tion.41 P. aeruginosa strains typically produce at least two side-
rophores, pyoverdine and pyochelin.43 Pyoverdines coordinate
Fe(III) with high aﬃnity (for pyoverdine PaA, Ka = 10
30.8 and
pFe(III) = 27),44 whereas pyochelin exhibits much lower aﬃnity
(Ka = 10
17.3 and pFe(III) = 16).45 Mathematical simulations
support the hypothesis that P. aeruginosa strains with the
capacity to switch between producing and utilizing these two
siderophores in response to changing iron conditions have an
enhanced degree of fitness over those that cannot.46
Although access to multiple siderophores can confer advan-
tages related to iron acquisition, another logical proposal is that
organisms may produce seemingly redundant siderophores
because some of these molecules are actually serving functions
other than iron delivery. Indeed, investigations into alternative,
non-classical functions of siderophores have revealed that this
scenario occurs. Studies approaching this problem from both
chemical and biological perspectives have revealed novel bioinor-
ganic chemistry. In this Perspective, we intend to provide the
reader with an overview of non-classical siderophore functions
and the connections that exist between them (Table 2). We also
intend for this exposition to spark new initiatives that will address
as-yet unconceived siderophore functions. We will limit our
discussion to biological siderophore functions, and we refer the
reader to a number of reviews on the technological potential
of siderophores, which, although arguably distinct from the
classical siderophore function, fall outside the scope of this
Perspective.47–50
In the following sections, we will begin with a non-classical
function that is perhaps the simplest extension from iron
transport: the transport of other essential metals such as zinc,
manganese, molybdenum, and vanadium. The interaction of
siderophores with copper and heavy metals will also be dis-
cussed. A digression from metal–siderophore interactions will
summarize the role that marine siderophores may play in
boron uptake. The focus will then shift from siderophores
binding ions and influencing mass transport to the putative
role of metal–siderophore complexes and apo siderophores as
signalling molecules. The ability of siderophores to protect
bacteria from oxidative stress will also be addressed. We will
conclude with a return to ferric siderophore complexes and
present sideromycins, antibiotic–siderophore conjugates that
exploit bacterial iron uptake machinery to enhance eﬃcacy.
Investigations into this non-classical siderophore function
may prove to be particularly valuable in the development of
therapies targeting the antibiotic-resistant pathogenic bacteria
that are infesting hospitals worldwide.
Siderophores as zincophores
Following iron, zinc is the most abundant transition metal in
E. coli.15 It has been estimated that approximately 5% of the
E. coli proteome comprises zinc-binding proteins.51 Given the
important structural and catalytic roles that Zn(II) plays in bac-
Chart 2 Chemical structures of the siderophores discussed in Sidero-
phores as Zincophores. The stereochemistry of yersiniabactin was taken
from ref. 31. *The structure of coelibactin is tentative and based on
bioinformatics analyses; stereochemistry has yet to be established.56
†Rhizoferrin can occur as shown (S,S) or in the enantiomeric (R,R) form.
‡Many pyoverdines exist and are distinguished by the nature of the
peptide chain attached at the R position. Pdtc is pyridine-2,6-dithiocar-
boxylic acid.
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terial proteins, it is not surprising that these organisms have
machinery, such as the ZnuABC transporter, dedicated to zinc
uptake.52 The importance of Zn(II) acquisition for bacterial
pathogens is underscored by the fact that humans secrete
zinc-sequestering proteins (e.g. calprotectin and psoriasin) to
inhibit the progression of microbial infections.53,54 It is possi-
ble that zinc-withholding by the host applies an evolutionary
pressure on pathogenic bacteria to develop high-aﬃnity zinc
uptake mechanisms akin to those in which siderophores play
a role.55 Little is known, however, about the extent to which
bacteria secrete high-aﬃnity zinc chelators, termed zincophores
or tsinkosphores.54
After the genome of the filamentous soil-dwelling bacter-
ium Streptomyces coelicolor was sequenced,57 two non-riboso-
mal peptide synthases (NRPSs) were identified and deduced to
be responsible for the biosynthesis of two small molecules,
namely coelichelin and coelibactin. The structures of these
molecules were predicted on the basis of bioinformatics ana-
lyses, which included identification of the specificity-determin-
ing residues of the NRPS adenylation domains that select and
activate monomeric precursors.58 Subsequently, the proposed
structure of coelichelin was amended following NMR studies
of its gallium complex.59 Comparison with known siderophore
structures suggested that coelichelin and coelibactin also func-
tion in iron transport. During later studies on the eﬀect of zinc
on the production of antibiotics by S. coelicolor, it was
observed that increased zinc levels decreased the expression of
coelibactin, as determined by qRT-PCR of the coelibactin
NRPS mRNA transcripts, and a putative zincophore activity
was ascribed to this molecule.60 Next, a study of the eﬀect of
coelibactin on S. coelicolor sporulation confirmed that Zur, the
zinc uptake repressor, regulates coelibactin biosynthesis.61
Although the biosynthesis of coelibactin has been investi-
gated,56,62 this metallophore has not yet been isolated from
S. coelicolor and structurally elucidated; thus, its coordination
chemistry remains to be explored.
A variety of pseudomonads produce the small molecule
metal chelator pyridine-2,6-dithiocarboxylic acid, or pdtc,
which was first identified as a result of its ability to bind iron
and was therefore described as a siderophore.63 Production of
this molecule has since been observed in both environmental
samples and in laboratory cultures of Pseudomonas stutzeri KC
grown either aerobically or anaerobically.64–66 The soft charac-
ter of the sulphur donor atoms of pdtc favours complex for-
mation with soft metals, providing higher aﬃnity for Fe(II)
than Fe(III). Pdtc also complexes zinc,67 and the ability of
pdtc to eﬀect biological transport of zinc was demonstrated
in Pseudomonas putida.68 Subsequent studies revealed that
the zinc–pdtc complex is recognized and transported by the
outer membrane receptor and inner membrane permease of
the pdtc utilization machinery; however, transport of zinc–pdtc
is much less eﬃcient than transport of the iron–pdtc
complex.69
Very recently, it has been demonstrated that yersiniabactin,
a heterocyclic siderophore produced by Yersinia pestis and
some pathogenic E. coli, can act as a zincophore.70 The ability
of Y. pestis znu mutants lacking functional ZnuABC transport
machinery to grow in response to supplementation of Chelex-
treated medium with zinc suggested that an unidentified high-
aﬃnity zinc transporter was operational.71 In support of this
proposition, none of the other divalent metal ion transport
systems of this organism mediated zinc uptake.71,72 Mutations
in the irp2 gene encoding the yersiniabactin synthetase HMWP2
produced severe growth defects when combined with a ΔznuBC
mutation. Bacterial growth was restored by either complementa-
tion with the irp2 gene in trans or Zn(II) supplementation.70
Moreover, addition of purified exogenous apo-yersiniabactin
stimulated growth in mutant Y. pestis strains lacking a
functional ZnuABC system. Remarkably, uptake of the yersinia-
bactin-complexed zinc requires neither the outer membrane
receptor nor the inner membrane ABC transporter that are
required for yersiniabactin-mediated iron transport, indicating
that a separate uptake pathway is operative.72 The interaction of
yersiniabactin with Zn(II) may have important implications for
human disease based on experiments in a mouse model of sep-
ticaemic plague. The ZnuABC transport system and HMWP2,
likely via its role in yersiniabactin synthesis, both contribute to
the development of lethal Y. pestis infections.70
Explicit studies of the zinc coordination chemistry of yersi-
niabactin appear to be lacking in the literature. In this context,
we note that the antibiotic micacocidin, produced by Pseudo-
monas sp. No. 57–250, complexes zinc as well as iron and
copper.73,74 The structure of micacocidin is identical to that of
yersiniabactin with the exception of methylation of the nitrogen
atom in the saturated thiazolidine ring and substitution of the
phenolic ring at the 3-position with an n-pentyl group. Micaco-
cidin forms a complex with Fe(III), known as micacocidin C, but
was not investigated as a siderophore until recently.75 In
addition to the Fe(III) complex, a Cu(II) complex, micacocidin B,
and a zinc complex, micacocidin A, were isolated from bacterial
cultures.73 Micacocidin A was the dominant product obtained
from bacterial culture and was characterized crystallographi-
cally.74,76 The crystal structure reveals a coordination geometry
resembling that of ferric–yersiniabactin (Fig. 1).31 One key
diﬀerence is that the deprotonated secondary alcohol in the
structure of the Fe(III) complex remains protonated in the Zn(II)
structure, resulting in charge neutrality for both compounds.
The Zn(II)-bound structure of micacocidin corroborates a
Fig. 1 Ball-and-stick representations of the metal complexes from the
crystal structures of (A) yersiniabactin–Fe(III) (CCDC ID: 619878)31 and (B)
micacocidin–Zn(II) (micacocidin A, CCDC ID: 130920).76 Non-polar
hydrogen atoms have been omitted for clarity. Colour code: C gray, O
red, N blue, H white, Fe orange, and Zn green.
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zinc-related non-classical function for yersiniabactin, and high-
lights the need for detailed investigations of the zinc coordi-
nation chemistry of the latter siderophore.
The interaction of siderophores with manganese
Manganese is another essential nutrient and, in prokaryotes,
Mn-containing metalloproteins carry out functions ranging
from photosynthesis to oxidative stress defence.77 The metal-
withholding host-defence paradigm described above in
relation to iron and zinc extends to manganese as well.53 Bac-
terial protein-based uptake systems for manganese have been
described in Gram-negative and -positive strains, and further
studies continue to reveal how these proteins contribute to
manganese homeostasis.78,79 The bacterial manganese trans-
port protein MntC and its homologues are extra-cytoplasmic
solute-binding proteins that bind Mn(II) and interact with
other members of the ABC transporter to bring the divalent
metal ion into the cell.77,80 In addition, small molecules may
also be exported by cells to bind Mn(II) with high aﬃnity and
facilitate cellular uptake.81 A molecule fulfilling such a nutri-
tional role has yet to be definitively identified, however.
Bacterial Mn metabolism contributes to the global redox
cycling of this element.82 Mn(II) is readily soluble in water but
more highly oxidized species typically deposit in the environ-
ment as insoluble Mn(III,IV) oxide minerals. Numerous micro-
organisms catalyse the oxidation of Mn(II), although whether
this chemistry serves a biological function has yet to be defini-
tively ascertained.83 The enzyme-catalysed oxidation is pro-
posed to proceed through sequential one-electron transfer
steps, generating Mn(III) intermediates.84–86 Indeed, such one-
electron transfers are proposed to contribute to the persistent
levels of soluble Mn(III) observed in suboxic zones.81 The most
widely studied manganese-oxidizing bacteria are fluorescent
pseudomonads.87 The luminescence of these microbes results
from production of pyoverdine siderophores. These sidero-
phores impact manganese metabolism, forming Mn-pyoverdine
complexes. For instance, the Mn(II)-oxidizing strain P. putida
MnB1 produces the pyoverdine PVDMnB1.
88 This molecule has
all of the properties expected of a siderophore, but has a
reported binding aﬃnity for Mn(III) that is almost 1000-fold
greater than that for Fe(III).88 Mutant strains that overexpress
pyoverdine demonstrate a reduced capacity to carry out Mn(II) to
Mn(IV) oxidation.89 Similar results were obtained using P. putida
GB-1, which produces the pyoverdine PVDGB-1.
87
The investigation of siderophore–Mn(III) coordination
chemistry was extended to other pyoverdines and rhizoferrin,
and these molecules also coordinated Mn(III) with greater
aﬃnity than Fe(III).90 It was proposed that the large sidero-
phore–Mn(III) stability constants derive from the ability of
these siderophores to accommodate the Jahn–Teller distortion
of the high-spin d4 Mn(III) centre.90
We also briefly note here, in relation to biogeochemical
cycling, that various hydroxamate and catecholate sidero-
phores facilitate the dissolution of oxyhydroxide minerals con-
taining Mn as well as Co, Cr, and Fe.91–93
Fuelling nitrogenase: molybdenum and vanadium
Nitrogenases are enzymes produced by diazotrophs that carry
out the chemically challenging six-proton, six-electron
reduction of dinitrogen to two equivalents of ammonia in
water under ambient conditions.94 The key to this transform-
ation is an iron–sulphur-containing inorganic cofactor present
within the enzyme. Whereas some bacterial strains produce
nitrogenases with iron as the only metal in the cofactor, other
strains incorporate molybdenum or vanadium into the cofac-
tor as well.94–96 Early studies identified aminochelin as a cat-
echolamine siderophore produced by the nitrogen-fixing
diazatroph Azotobacter vinelandii that coordinates both iron
and molybdenum.97 Using aminochelin, A. vinelandii was able
to strip molybdenum from silicate samples.98 Further studies
on this model organism revealed that the siderophores it pro-
duces under Mo- and V-limiting conditions form stable com-
plexes of these metals.99 The biscatechol and triscatechol
siderophores, protochelin and azotochelin, are secreted under
these conditions and form 1 : 1 complexes with vanadate and
molybdate as evidenced by tandem high performance liquid
chromatography-inductively coupled plasma mass spec-
trometry.99,100 Isotopically-enriched metal–siderophore com-
plexes were used to confirm cellular uptake of the Mo- and
V-bound forms of the metallophores. A. vinelandii also pro-
duces a pyoverdine-like siderophore called azotobactin that
contains each of the three metal-binding motifs typical of side-
rophores: hydroxamate, catecholate, and α-hydroxycarboxylate.
Like protochelin and azotochelin, azotobactin coordinates
vanadate and molybdate to form complexes that are trans-
ported into the bacterium.101 Experiments using mutant
strains deficient in the production of either azotobactin or the
catecholate siderophores suggest that the latter are preferen-
tially used to take up iron and the former, molybdenum.102
Although not related to an explicit biological function, we
mention briefly here that, for many years, the vanadium
complex of enterobactin was the closest analogue of the ferric
complex of this archetypal siderophore to be characterized by
Chart 3 Chemical structures of the siderophores discussed in Fuelling
Nitrogenase: Molybdenum and Vanadium. ‡Azotobactin has a peptide
chain as the R substituent.
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atomic-resolution X-ray crystallography (Fig. 2).103,104 Recently,
structures of the silicon (Fig. 2), germanium, and titanium
complexes of enterobactin were reported.105 This work was
motivated by the observation that enterobactin and salmoche-
lin S4 bind silicon.106 Further insight into the structure of
enterobactin can be obtained from crystal structures of ferric
enterobactin complexed with diﬀerent proteins. Early macro-
molecular structures of lipocalin-2 bound to enterobactin
suggested that the trilactone was at least partially hydrolysed
(Fig. 3).107,108 A crystal structure of lipocalin-2 bound to what
appears to be a non-hydrolysed ferric enterobactin complex
was deposited in the protein databank in 2008 (PDB ID: 3CMP,
Fig. 3), but no follow-up publication has appeared in the litera-
ture. More recently, a crystal structure was obtained of ferric
enterobactin complexed with FeuA, a component of the trisca-
techolate siderophore transport machinery of Bacillus subtilis
(Fig. 3).109
The interaction of siderophores with copper
The concentration and localization of copper within cells is
tightly regulated because of its propensity to catalyse deleter-
ious Fenton-like chemistry.110 Moreover, cellular over-accumu-
lation of copper leads to toxicity.111 Thus, bacterial copper
transport proteins and chaperones are employed to control
intracellular copper concentrations.112–116 Although numerous
studies have uncovered many aspects of the mechanisms by
which bacteria use proteins to chaperone, sequester, and
eﬄux copper, less is known about the means by which bacteria
import copper.116 Methanotrophic bacteria require particularly
large supplies of copper to produce functional particulate
methane monooxygenase.117,118 This enzyme allows the bac-
teria to derive energy and the carbon they need for anabolic
processes from methane.119 Analysis of the growth medium in
which methanotrophs were cultured under copper-limited con-
ditions revealed the presence of small molecules that bind
Chart 4 Chemical structures of the siderophores discussed in The
Interaction of Siderophores with Copper. The stereochemistry of
yersiniabactin was taken from ref. 31. The enantiomer of the form of pyo-
chelin shown, enantio-pyochelin, is a known siderophore. ‡Many pyover-
dines exist and are distinguished by the nature of the peptide chain
attached at the R position. Pdtc is pyridine-2,6-dithiocarboxylic acid.
Fig. 2 Thermal ellipsoid diagrams from the crystal structures of the (A)
vanadium and (B) silicon complexes of enterobactin (CCDC ID: 624678
and 920703, respectively).103,105 Thermal ellipsoids are drawn at the 50%
probability level and hydrogen atoms are shown as spheres of arbitrary
radius. Colour code: C gray, O red, N blue, V purple, and Si green.
Fig. 3 Lipocalin-2 bound to either (A) hydrolyzed or (B) non-hydrolyzed ferric enterobactin (PDB ID: 3BY0 and 3CMP, respectively).108 (C) Non-
hydrolyzed ferric enterobactin complexed with FeuA (PDB ID: 2XUZ).109 In all panels, the protein is shown as a wheat-coloured surface. The ligands
of the protein-bound small molecule are shown as sticks and the iron atom as a sphere. Colour code: C grey, O red, N blue, and Fe orange.
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copper with high aﬃnity.120,121 The compound identified in
these studies that has received the most significant attention
is called methanobactin.122,123 This peptidic compound has
been alternately referred to as a copper-binding ligand (CBL), a
copper-binding compound (CBC), or a chalkophore. These
names all serve to evoke an identical impression: this molecule
binds copper ions and transports them into the cell.123 Other
molecules have been proposed to act as chalkophores, includ-
ing coproporphyrin III, which is secreted by Paracoccus denitri-
ficans under copper-limiting conditions to ensure an adequate
supply of copper to the enzymes involved in denitrification.124
The ubiquitous small molecule glutathione avidly binds
copper but is thought to play a role in detoxification as
opposed to transport.125
In addition to the small molecules described above, do
siderophores bind copper? Similar to Zn(II), Cu(II) ions are
softer than Fe(III) ions and so many of the siderophores that
are well-tuned to complex ferric ions within a field of hard
ligands will not interact as favourably with cupric ions. These
two metal ions also prefer that their ligand fields assume
diﬀerent geometries, suggesting a lack of interaction between
copper ions and siderophores pre-organized to bind Fe(III).
Nonetheless, siderophores with softer donor atoms interact
with copper. In the instances described below, this interaction
is proposed have a specific biological purpose.
The pdtc metal-binding studies described above also identi-
fied copper as a metal that is coordinated by this sidero-
phore.67 A number of early studies on pdtc focused on the
ability of its metal complexes to dehalogenate carbon tetra-
chloride,64,65 and the cupric pdtc complex was identified as
the most active species.126 Although pdtc can act as a sidero-
phore, it does not appear to be used by bacteria to increase
intracellular copper concentrations.127 The copper pdtc
complex is capable of redox cycling, which may contribute to
an as-yet undetermined biological function of this complex.67
Insight into the role that pseudomonal siderophores play in
copper regulation was obtained by monitoring changes in the
transcriptional profiles of P. aeruginosa following exposure to
elevated copper concentrations.128 These studies indicated
that production of high-aﬃnity pyoverdine siderophores
increased under high-copper conditions, whereas levels of the
low-aﬃnity siderophore pyochelin decreased. These results
were interpreted to indicate that pyochelin may be involved in
the uptake of copper.128 This proposal is in agreement with
previous experiments, which revealed a decrease in pyochelin
synthesis upon incubation of P. aeruginosa with copper as well
as molybdenum, nickel, or cobalt.129 Studies of the coordi-
nation chemistry of pyochelin confirmed that it forms stable
complexes with Cu(II) and Zn(II).45
Some small molecules, such as glutathione, that interact
with copper in bacterial cells do so to mitigate the toxicity of
this element.130 Copper, particularly Cu(I), is suﬃciently toxic
that mammals may use it as a bactericidal agent to combat
microbial infection.131 For example, cultured RAW264.7
mouse macrophage cells and peritoneal macrophages from
freshly sacrificed mice appear to pump copper into phago-
somes containing E. coli in order to kill the bacteria.132,133
Above, an immune response was described in which a host
fends oﬀ an invading pathogen by starving it of essential nutri-
ents. The pathogen can respond by secreting molecules, such
as siderophores, to bind the nutrient metal ion with high
aﬃnity and increase its uptake. The situation is reversed with
copper given that the microbe is bombarded with an excess of
a nutrient, but surprisingly an increase in siderophore pro-
duction again appears to be a viable survival strategy, as
described below.
An investigation of the response of pathogenic bacteria to
increased copper concentrations revealed that the microbes
increase expression of eﬄux proteins and oxidases, and
secrete molecules to sequester reactive copper species.130 Glu-
tathione and MymT, a bacterial metallothionein produced by
Mycobacterium tuberculosis in response to high levels of
copper, attenuate Cu(I) toxicity.113,114,125,134 Moreover, mole-
cules traditionally viewed as siderophores are employed by bac-
teria to grow under toxic concentrations of copper. In
particular, yersiniabactin binds Cu(II) ions and prevents
reduction to the more toxic Cu(I) oxidation state.135 Conversely,
catecholate-containing siderophores, such as enterobactin,
reduce Cu(II), producing toxic cuprous ions.136 As described
below, the redox-active catechol moieties of enterobactin can
alternatively play a cytoprotective antioxidant role.
Uropathogenic E. coli UTI89 delicately balance the desired
iron-binding and undesired copper-reducing chemistry of cate-
cholate siderophores. In the current model,135 E. coli UTI89
produce yersiniabactin and enterobactin to sequester iron
from host proteins. To combat infection, the host increases
Cu(II) concentrations in the vicinity of the bacteria and these
cupric ions react with the catecholate moieties of enterobactin
to produce toxic cuprous ions. Increased production of yersi-
niabactin allows Cu(II) to be sequestered before it is
reduced.135 The cupric yersiniabactin complex is stable and
has been detected in the urine of patients infected with uro-
pathogenic E. coli.135 It should be noted that expression of
CueO, typically designated as a cuprous oxidase, can also be
increased to mitigate the toxic eﬀects of copper by oxidizing
the enterobactin precursor 2,3-dihydroxybenzoic acid to 2-car-
boxymuconate, thereby preventing catechol-mediated
reduction of Cu(II).136
The copper–yersiniabactin complex is competent to eﬀect
superoxide dismutation.133 As noted above, expression of
yersiniabactin confers a survival advantage upon pathogenic
E. coli that are engulfed by macrophages. In addition to Cu(II)
sequestration, the superoxide dismutase activity of copper–
yersiniabactin may help to reduce the level of NADPH oxidase-
derived superoxide that is produced by the macrophage to kill
internalized bacteria.
Finally, we note that the ability of yersiniabactin and pyo-
chelin to function in copper sequestration relies on the
inability of the copper–siderophore complexes to interact with
the receptors and transport proteins that mediate uptake of
ferric siderophores. Nonetheless, experiments with the sidero-
phore schizokinen indicate that this distinction is not univer-
Dalton Transactions Perspective
This journal is © The Royal Society of Chemistry 2015 Dalton Trans., 2015, 44, 6320–6339 | 6327
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
8 
Fe
br
ua
ry
 2
01
5.
 D
ow
nl
oa
de
d 
on
 3
0/
04
/2
01
5 
17
:2
3:
05
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
sal. Production of this siderophore increases the sensitivity
of Bacillus megaterium to copper by increasing intracellular
Cu accumulation, but has the opposite eﬀect in Anabaena
spp.137,138 In addition to copper transport by schizokinen, it is
possible that alteration of iron uptake dynamics may factor
into the ultimate toxicity observed in these experiments.
Other metals: transport and sequestration
The coordination chemistry of a variety of siderophores has
been studied using metals other than iron or those described
above.67,139 In addition to fundamental investigations of the
abiological inorganic chemistry of some siderophore com-
plexes,140 a number of reports have focused on the broad-spec-
trum metal-binding capabilities of siderophores to probe the
abilities of these ligands to mitigate or exacerbate the toxicity
of heavy metals. The work described above on the protochelin-
mediated transport of Fe, Mo, and V in A. vinelandii, which is
important in evaluating the ability of this organism to satisfy
the metal requirements of nitrogenases, was extended to
include Cr and Co.141 Protochelin is unlikely to play a role in
the intracellular accumulation of Cr and Co, but interactions
of these metals with protochelin have implications for Cr/Co
biogeochemical cycling.141
The ability of the siderophores produced by Pseudomonas
spp. to complex metals other than iron has received significant
attention because of the prevalence of these bacteria in soil
and marine environments as well as their classification as
opportunistic human pathogens.145 The pseudomonal sidero-
phores pyochelin and pyoverdine form complexes with over 15
diﬀerent transition metal and main group metal ions.146,147
Moreover, these siderophore complexes were able to interact to
varying degrees with their cognate receptors – the pyochelin
complexes with FptA (Kd = 10 nM–4.8 μM) and the pyoverdine
complexes with FpvA (Kd = 2.9 nM–13 μM).148,149 Despite the
interaction that the non-iron pyochelin and pyoverdine com-
plexes have with the appropriate outer membrane receptor, cel-
lular accumulation was either absent or, in a few cases,
present to a degree substantially less than that of the corres-
ponding ferric complex.148 Subsequent investigation revealed
that the outer membrane transporters both recognize the non-
iron metal complexes and import the complexes into the
cell.149 The lack of observed intracellular accumulation arises
from the ATP-dependent eﬄux pump PvdRT-OpmQ, which
exports pyoverdine complexes of unwanted metals. These pro-
perties have led to the investigation of Pseudomonas spp. as
potential bioaugmentation agents in the phytoremediation of
soils contaminated with environmental pollutants such as
chromium, lead, and mercury.150,151
Pdtc, the small thiocarboxylate-containing tridentate sidero-
phore described above, was also interrogated for its ability to
complex a wide range of metals and metalloids.67 This ligand
typically assumes a 1 : 2 metal-to-ligand ratio, aﬀording an
octahedral coordination sphere (Fig. 4). The ligand complexed
14 diﬀerent metals and exerted a protective eﬀect on Pseudo-
monas spp., Staphylococcus spp., an Arthobacter sp., Bacillus
spp., E. coli, and Candida albicans that were incubated with
mercury. Some of these organisms were also protected from
cadmium and tellurium exposures.152
Although the work described above illustrates the ability of
some siderophores to interact with a range of soft, heavy
metals, it is not surprising that many siderophores interact
better with smaller, harder metal ions. For instance, desfer-
rioxamine B (DFOB) binds Fe(III), Al(III), Ga(III), and In(III) with
log β110 values of 31.0, 24.5, 28.7, and 21.4, respectively.
155
This tight binding interaction is exploited to treat iron over-
load disorders, such as thalassemia, and aluminium overload
Chart 5 Chemical structures of the siderophores discussed in Other Metals: Transport and Sequestration and Marine Siderophores and Boron. The
enantiomer of the form of pyochelin shown, enantio-pyochelin, is a known siderophore. ‡Many pyoverdines exist and are distinguished by the nature
of the peptide chain attached at the R position. *The stereochemistry of the delftibactins has not been reported.142,143 The chemical structure of
vibrioferrin was obtained from ref. 144. Pdtc is pyridine-2,6-dithiocarboxylic acid.
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arising from ingestion of high levels of aluminium.156,157 The
siderophore schizokinen and its N-deoxy derivative, produced
by B. megaterium, also bind aluminium.158 The aluminium–
siderophore complex was delivered into the cell through the
siderophore transport receptor, leading to increased intracellu-
lar accumulation of aluminium.
In at least one instance, the strength of the interaction
between a siderophore and aluminium resulted in the un-
intended complexation of the two.159,160 Initial studies of the
interaction of pyoverdine with its cognate outer membrane
transporter FpvA appeared to indicate that the transporter
bound the apo-siderophore with high aﬃnity.161 In depth
investigation revealed that the strong transporter-small mole-
cule interaction was in fact with the aluminium complex of
pyoverdine, formed from trace amounts of aluminium in the
buﬀers used for the experiments. The aluminium complex
exhibits enhanced fluorescence as compared to the apo-sidero-
phore,162 which confounded the initial interpretation of the
fluorescence resonance energy transfer data that were used to
investigate pyoverdine-FpvA binding. We also note in passing
that the first siderophore to be isolated, mycobactin (later
renamed mycobactin P),163 was initially isolated as an alu-
minium complex, the facile crystallization of which permitted
detailed studies to be carried out on pure material.164–166 The
aluminium most likely originated from the alumina column
that was used in the chromatographic preparation of the bac-
terial cell extract under investigation and is not involved in the
biological function of mycobactin P.
Pu(IV) exhibits coordination chemistry similar to that of
Fe(III). The bioinorganic chemistry of plutonium is often
studied with the aim of understanding its toxicity. Plutonium
can bind transferrin and enter mammalian cells via the ferric
transferrin uptake machinery.167 The interplay between pluto-
nium and microorganisms has also been investigated. Desfer-
rioxamine (DFO) siderophores display high aﬃnity for
Pu(IV);168 for Pu(IV)-DFOB, log β110 = 30.8 and Pu(IV)-DFOE is
suﬃciently stable that its crystal structure was determined
using X-ray diﬀraction methods (Fig. 5).169,170 Studies with the
DFOB-producing bacterium Microbacterium flavescens JG-9
demonstrated that the Pu(IV)-DFOB complex was taken up by
living, metabolically-active bacteria.171 As reviewed recently,172 a
number of subsequent studies have shown that, through the use
of siderophores, microorganisms can dissolve plutonium and sig-
nificantly aﬀect its subsurface and environmental distribution.
The last example we will present in this section involves the
delftibactins. These siderophore-like molecules are produced
by the bacterium Delftia acidovorans and are products of NRPS
machinery. The genes encoding the NRPS are clustered with
genes of other siderophore synthases as well as siderophore
transporters and regulators.142 Like Cupriavidus metallidurans,
D. acidovorans colonizes the surface of gold nuggets.173 The
delftibactins produced by D. acidovorans protect the bacterium
from the toxic eﬀects of gold and enable biomineralization of
the metal as gold nanoparticles.142 Enterobactin, yersiniabac-
tin, and aerobactin were also tested for their ability to form
gold nanoparticles.143 Yersiniabactin and enterobactin were
able to form small and large amounts of colloidal gold par-
ticles, respectively. In neither instance, however, were the par-
ticles formed as well or in a similar amount as with
delftibactin A or B.143
Marine siderophores and boron
The estuarine enteropathogen Vibrio parahaemolyticus is
associated with episodes of gastroenteritis following consump-
tion of contaminated seafood.174 This bacterium produces
vibrioferrin,175 a citrate-based siderophore that is photoreac-
tive and displays a relatively low aﬃnity for Fe(III) (log β110 =
24.0) as compared to other marine siderophores.144,176 Vibrio-
ferrin was also identified in a search for siderophores in Mari-
nobacter spp., and was unexpectedly observed as the borate
complex (Fig. 6).177 Given that boron was not added to the
solutions from which the siderophore was isolated, the
authors proposed that vibrioferrin was stripping boron from
the borosilicate glassware used during the isolation procedure.
Fig. 4 Ball-and-stick representations of the metal complexes from the
crystal structures of (A) [Fe(pdtc)2]
− (NBS ID: 557651),153 (B) [Co(pdtc)2]
−
(NBS ID: 596508),154 and (C) [Ni(pdtc)2]
2− (NBS ID: 596506).154 Colour
code: C gray, O red, N blue, H white, Fe orange, Co pink, and Ni green.
Fig. 5 Molecular diagram of the siderophore complex from the crystal
structure of desferrioxamine E-triaquaplutonium(IV) (CCDC ID:
136339).170 Non-hydrogen atoms are shown as shaded spheres of arbi-
trary radius and hydrogen atoms have been removed for clarity. Colour
code: C gray, O red, N blue, and Pu orange.
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Further investigation revealed that a number of diﬀerent
citrate and catecholate siderophores form stable borate com-
plexes.177 Although borate is not typically present at very high
concentrations in terrestrial environments, it is common in
marine systems.178 It is not yet clear whether the borate–side-
rophore complex has biological relevance; however, functions
as either a boronophore or a signalling molecule have been
proposed.177,179–181
Recent studies with Marinobacter algicola DG893 revealed
that boron significantly influences the expression of at least
23 genes in this organism.182 A number of the influenced
genes are related to iron homeostasis. With the exception of
FbpA, a periplasmic iron-binding protein, the expression of all
of the iron uptake-related proteins examined increased with
increasing boron concentration. The authors proposed that
boron influences the iron uptake regulator, Fur.182 Investi-
gation into the interaction of borate with FbpA revealed that
the protein synergistically binds Fe(III) and borate, eﬀectively
facilitating sequestration of the metal.183 The mode of syner-
gistic borate binding was proposed to be analogous to that of
carbonate.184
We note that the Marinobacter genus was chosen as the
subject of the aforementioned studies because it is frequently
associated with toxic dinoflagellates such as Gymnodinium
catenatum and Scrippsiella trochoidea. These algae are proposed
to have a mutualistic relationship with Marinobacter whereby
photolysis of ferric vibrioferrin releases iron to the benefit of
the phytoplankton and the bacteria make use of the carbon
fixed by the eukaryote.185 This situation provides an example
of a siderophore being used to feed an organism other than
the producer to the benefit of the producer, in contrast to the
well-established ability of bacteria to compete with one
another by consuming xenosiderophores.186,187
Siderophores as signalling molecules
The iron that is transported into cells by siderophores can act
as a signalling agent, notably in the regulation of genes related
to iron homeostasis.188 It is also plausible that the siderophore
itself, or a metal complex thereof, acts directly as a signalling
molecule.189 For example, the boron complex of vibrioferrin
may act as either a traditional signalling molecule or a
mediator of quorum sensing as described above.181 The use of
siderophores as signalling agents by Pseudomonas spp. is likely
the most widely investigated manifestation of this chemical
communication strategy.190–192 The pyoverdines produced by
P. aeruginosa strains serve not only to supply the bacteria with
essential iron, and possibly carry out functions related to its
binding to other metals as described above, but also regulate
the expression of three virulence factors: exotoxin A, an endo-
protease, and pyoverdines themselves.43,193 Because the sidero-
phore is secreted, it can signal within one bacterium as well as
mediate communication between bacteria.194 As a conse-
quence of the regulatory eﬀects that pyoverdines have on these
virulence factors, mutants of the plant pathogen Pseudomonas
syringae pv. tabaci 6605 deficient in their capacity to produce
this siderophore exhibited reduced virulence in host tobacco
infection.195 Enhanced swarming ability and increased biosur-
factant production were also phenotypic eﬀects of the pyover-
dine deficiency.
An early example of siderophores being used as signalling
molecules came from the observation that some marine bac-
teria use exogenous siderophores to stimulate the production
of endogenous siderophores.196 For example, growth of the
α-proteobacterium strain V0210 was stimulated by the addition
of N,N′-bis(2,3-dihydroxybenzoyl)-O-serylserine, a siderophore
produced by Vibrio spp.196
Members of the Bordetella genus, including the pathogen
Bordetella pertussis that causes whooping cough in humans,
employ a range of alternative iron acquisition mechanisms to
adapt to fluctuations in iron concentration during the course of
Fig. 6 Ball-and-stick model of the proposed structure of the vibriofer-
rin–borate complex. The structure was minimized with GaussView
based on that depicted in ref. 177. Color code: C gray, O red, N blue, H
white, and B pink.
Chart 6 Chemical structures of the siderophores discussed in Sidero-
phores as Signalling Molecules. The stereochemistry of yersiniabactin
was taken from ref. 31. ‡Many pyoverdines exist and are distinguished by
the nature of the peptide chain attached at the R position. The chemical
structure of vibrioferrin was obtained from ref. 144.
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infection.197 In Bordetella spp., the siderophores alcaligin and
enterobactin function as inducers that activate expression of
their cognate transport systems.198 Because of this signalling
capacity, these complexes have been referred to as ferrimones.198
In Y. pestis, yersiniabactin can activate the transcription of
the yersiniabactin outer membrane receptor (psn), the yersinia-
bactin synthetase HMWP2 (irp2), and a transcriptional regu-
lator (ybtP). It also decreases expression of ybtA, another
transcriptional regulator.199,200 Importantly, yersiniabactin
influenced transcription at concentrations 500-fold lower than
those at which it exerted a nutritional eﬀect, indicating that its
signalling role functions independently of its nutritional
role.199 These genes, as well as yersiniabactin-mediated modu-
lation of gene expression, were essential for Y. pestis to cause
pneumonic and bubonic plagues in murine models.201 We
note that yersiniabactin-like molecules of unconfirmed struc-
ture produced by mutants with non-functional salicylate
synthase YbtS or mutants that lack all ybt genes except for
ybtD, a putative phosphopantetheinyl transferase, also modu-
lated gene transcription in a similar manner.202 Although
these yersiniabactin analogues are not biologically relevant
per se, such structure–activity relationship studies may provide
insight into the nature of yersiniabactin signalling.
Protection from oxidative stress
During an investigation of the antibiotic properties of pyoche-
lin, enterobactin was observed to play a role in mitigating the
deleterious eﬀects of oxidative stress.203 Addition of pyochelin
to E. coli increased levels of reactive oxygen species (ROS). The
deleterious eﬀects of these ROS were abrogated as a result of
enterobactin production. Moreover, exogenous enterobactin
supplementation provided protection to an entE mutant that
could not biosynthesize enterobactin. Notably, this function is
associated with the redox activity of the enterobactin catecho-
lates rather than iron transport.204 Moreover, E. coli strains
that cannot produce enterobactin are unable to form colonies
on minimal medium. This eﬀect could not be reversed with
iron supplementation; however, addition of enterobactin or a
reducing agent such as ascorbic acid to the agar allowed the
colonies to form, as did anaerobic incubation. On the basis of
these results, the catecholate moieties of the siderophore are
proposed to scavenge radicals.204
A similar siderophore-mediated protective eﬀect was
observed in Salmonella enterica serovar Typhimurium.207 This
enteric pathogen produces enterobactin and a series of gluco-
sylated enterobactin derivatives known as salmochelins. The
primary means by which these siderophores confer virulence
is acquisition of iron from the host.42 Recent studies indicate
that these catecholate-based siderophores may also protect Sal-
monella from the oxidative stress encountered upon entering
the macrophage. The enhanced survival of Salmonella produ-
cing salmochelins, as compared to mutant strains deficient in
salmochelin biosynthesis and uptake, occurred primarily
during the early stage of infection when the macrophage typi-
cally unleashes a cytotoxic oxidative burst. In vitro studies con-
firmed that catecholate siderophores, but not yersiniabactin or
Chart 7 Chemical structures of the siderophores discussed in Protection from Oxidative Stress. The stereochemistry of yersiniabactin was taken
from ref. 31. The chemical structures of staphyloferrin A and staphyloferrin B were obtained from ref. 205 and 206. The structure of salmochelin S2
is that reported in ref. 32. An alternative structure of a linearized salmochelin S4 in which a glucosyl unit is attached at the carboxylic acid end of the
linearized trimer instead of the alcohol end has also been reported.33 The stereochemistry of aerobactin is drawn so as to be consistent with the
observation that only L-lysine is released upon degradation of this compound.245
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aerobactin, could protect Salmonella against oxidative stress
and that the siderophore needed to be taken up into the cell to
have this eﬀect.207
The redox-mediated cytoprotective function of catecholate
siderophores is reminiscent of the ability of cupric yersiniabac-
tin to act as a superoxide dismutase and protect macrophage-
internalized pathogens from oxidative stress.133 As described
above, however, results from the yersiniabactin studies put
forward a role for the catecholate moieties of enterobactin in
the generation of toxic cuprous ions that are used by the host
organism to stem bacterial infections.135 The combined
results of these experiments indicate that catecholate sidero-
phores can switch between cytoprotective and cytotoxic roles
depending on the nature of the molecules in the environment
surrounding the bacterium.
Staphylococcus aureus produces two citrate-based sidero-
phores, staphyloferrin A and staphyloferrin B.208 The
SirABC protein system mediates uptake of the siderophore
staphyloferrin B and contributes to virulence.209 Under
oxidative or nitrosative stress, S. aureus increases expression of
sirA, as detected by qRT-PCR,210 which conferred enhanced
resistance to oxidative stress. It remains unclear whether
this eﬀect simply results from enhanced iron uptake or
some other process.210 Staphyloferrin B does not contain cate-
cholate moieties,205,211,212 so a direct analogy to the protective
role that enterobactin plays in this regard is unwarranted.
Sideromycins: siderophores as antibiotics
Sideromycins are a class of antibiotics in which the bacteri-
cidal warhead is attached to a siderophore.213 The siderophore
moiety performs targeting and delivery functions and thereby
aﬀords enhanced cellular uptake of the antibiotic for strains
expressing the appropriate transport machinery. This “Trojan
horse” drug delivery strategy has been employed in the design
of a number of synthetic constructs aimed at enhancing thera-
peutic eﬃciency or overcoming antibiotic resistance.214–218
Examples include catecholate,219,220 hydroxamate,221 and car-
boxylate222 siderophore conjugates. The significant, and
growing, body of work on synthetic siderophore-antibiotic con-
jugates is a fertile ground for further investigation, and we
refer the reader to the aforecited recent reviews on the topic.
Here, we will restrict our discussion to those siderophore-anti-
biotic conjugates that occur naturally.
Naturally occurring sideromycins were discovered before
siderophores,223 with the identification of a substance called
grisein produced by Streptomyces griseus.224 This compound is
a member of a class of sideromycins called albomycins
(Chart 9). These sideromycins feature a hydroxamate sidero-
phore unit consisting of three N5-acetyl-N5-hydroxyornithine
moieties, reminiscent of those found in fungal ferrichromes.20
The C-terminus of the siderophore tripeptide motif harbours a
serine that is linked to a nonproteinogenic α-amino acid with
a 4-thioxylofuranose side-chain. The modified furanose ring is
bound to a cytosine, and modifications to the thioribosyl pyri-
midine antibiotic group distinguish the diﬀerent members of
this family.225 In all three albomycins, the pyrimidine is
methylated at the N3 position. In albomycin δ1, the cytosine
N4 is carbamoylated and in albomycin ε it is not. In albomycin
δ2, the N
3-methylcytosine is replaced with N3-methyluracil.25
These conjugates display a broad-spectrum of antibiotic
activity against both Gram-negative and Gram-positive bacteria
because of the widespread nature of transport proteins
capable of binding ferrichrome-type siderophores.213,226 The
antibiotic activity stems from the ability of the pyrimidine unit
to inhibit seryl-tRNA synthetase.227 One intriguing feature of
the albomycins is that the protein synthesis inhibitor is
cleaved from the siderophore unit by intracellular peptidases
to unleash antibiotic activity.228,229 We briefly note that this
feature of natural sideromycins can be used to inform the
design of synthetic siderophore-antibiotic conjugates, in
which a cleavable linker may be required.215,217,219
Salmycins (Chart 9), produced by a particular strain of
Streptomyces violaceus, are another class of well-studied sidero-
mycins.213 They comprise a ferrioxamine siderophore unit con-
jugated to an aminodisaccharide.230 Four salmycins,
salmycins A–D, have been identified. In each case, the sidero-
phore unit is danoxamine. Salmycins A and D are oximes of
salmycins B and C, respectively. The aminodisaccharide unit is
presumed to inhibit protein synthesis similarly to other ami-
noglycosides.174 Danomycins A and B, the former of which is a
carbamate of the latter, also feature a danoxamine iron-
binding unit and an aminodisaccharide that inhibits protein
synthesis,231 but the detailed structures of these compounds
remain unknown.232
Although three ferrimycins, A1, A2, and B, were isolated
from Streptomyces griseoflavus ETH 9578, a comprehensive
structural analysis appears to only be present for ferrimycin A1
(Chart 9).213,223,232–234 This compound features a DFOB sidero-
phore unit linked to an iminoester-substituted lactam, via a
4-amino-5-hydroxybenzoate linker.26 The heterobicyclic anti-
biotic warhead inhibits protein synthesis as demonstrated by
studies monitoring the cellular incorporation of radiolabeled
Chart 8 Chemical structures of the siderophores discussed in Sidero-
mycins: Siderophores as Antibiotics. The enantiomer of the form of pyo-
chelin shown, enantio-pyochelin, is a known siderophore.
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phenylalanine by S. aureus.235 In contrast to the albomycins,
which exhibit broad-spectrum antimicrobial activity, the sal-
mycins, danomycins, and ferrimycins are typically active only
against Gram-positive bacteria.213
The final class of sideromycins that will be discussed is the
siderophore-modified microcins. Microcins are small, riboso-
mally synthesized antimicrobial peptides that are produced by
Gram-negative bacteria and used as narrow-spectrum anti-
biotics.236 A number of microcins have been described, and
diﬀerent classification schemes have been put forth to categor-
ize these molecules. A recently devised schema distinguishes
between (i) class I microcins, which exhibit extensive backbone
post-translational modification and are <5 kDa; (ii) class IIa
microcins, which have no post-translational modifications
except disulfide bonds and molecular weights in the 5–10 kDa
range; and (iii) class IIb microcins that are linear polypeptides
and may carry a C-terminal post-translational modification.237
In this classification scheme, the class IIb microcins corre-
spond to the catecholate microcins. These peptides are post-
translationally modified with glucosylated catecholate sidero-
phores, presumably to enhance cellular uptake by strains
expressing catecholate siderophore receptors.237 The class IIb
microcins include MccE492, MccH47, MccI47, MccG492, and
MccM. MccE492 was the first discovered to exhibit the catecho-
late siderophore modification, producing a form named
MccE492m.238 The post-translational modification is a linear
trimer of 2,3-dihydroxybenzoylserine attached to the serine-84
carboxylate at the C-terminus of the peptide via a β-D-glucose
linker (Chart 9). Eﬀectively, the microcin is modified with a
linearized and monoglucosylated enterobactin moiety.32 Sub-
sequently, biochemical studies confirmed that MccM and
MccH47, which were putatively assigned as siderophore–
microcin conjugates based on bioinformatics analyses,239 each
contain C-terminal salmochelin-like post-translational modifi-
cations.240 Chemical verification of the structures of MccG492
and MccI47 remains to be obtained.
Although MccE492 is potent in its unmodified form, with
minimal inhibitory concentrations of 0.3 μM in assays with
various E. coli and Salmonella strains, the antimicrobial
activity increases ca. 10-fold upon catecholate siderophore
modification.238 The increased activity of the modified micro-
cin relies on the presence of siderophore uptake machin-
Table 2 Biological functions of bacterial siderophores
Iron transport The classical function of siderophores in
which they are secreted to bind iron and
transport it within bacteria to satisfy a
nutritional iron requirement
Non-iron metal
transport
Siderophores can bind other essential metals
like Zn, Mo, V, and Mn to mediate their
cellular uptake
Non-metal transport Elements such as boron and silicon can bind
siderophores and may be used by bacteria to
take up these elements
Toxic metal
sequestration
Heavy metals can be bound by siderophores
to prevent their cellular entry
Protection from
oxidative stress
Catecholate-bearing siderophores can
scavenge harmful radicals and cupric
yersiniabactin can function as a superoxide
dismutase
Molecular signalling Siderophores can regulate gene expression
and potentially function in quorum sensing
Antibiotic activity Siderophores can be conjugated to antibiotic
warheads to increase eﬃcacy
Chart 9 Natural sideromycins of known structure. The iron-binding siderophore unit is black, the antibiotic warhead is shown in red, and if a linker
is present it is shown in blue. *It is also possible that water is added such that this position bears a gem-diol.
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ery.238,241 Although the class I microcin MccJ25 does not
become post-translationally modified with a siderophore, it
interacts with the ferrichrome receptor FhuA.242 Recent X-ray
crystallographic characterization of the complex of MccJ25 and
FhuA revealed that the peptide mimics the binding of the side-
rophore to its receptor.243
Conclusions and outlook
The study of siderophores has provided an opportunity for fun-
damental studies in coordination chemistry to make impor-
tant contributions to understanding biological systems.
Elucidation of the multifaceted role of a bacterial siderophore
in metal homeostasis and bacterial physiology is a multidisci-
plinary endeavour that requires input from chemists, biochem-
ists, and microbiologists. Approaching siderophores from a
chemical standpoint is important for studies of non-classical
siderophore functions. Undoubtedly, one of the most stunning
attributes of siderophores is their ability to bind iron with
remarkable aﬃnity. Nevertheless, siderophores have a multi-
tude of other chemical properties, and we now appreciate that
bacteria will employ a siderophore for a secondary function pro-
vided that the siderophore can perform the requisite chemistry.
In the coming years, we expect that initiatives focused on
the ability of siderophores to acts as metallophores for other
elements will continue on several fronts. Of particular interest
is how this coordination chemistry contributes to metal-
sequestering host-defence strategies and bacterial pathogen-
esis. Additionally, the influence of bacteria on the biogeo-
chemical movement and environmental distribution of heavy
metals via siderophore production is a rich area for continued
investigation. Concerns over the fate of nuclear waste, particu-
larly in the wake of natural disasters, will likely drive investi-
gation into interactions of f-block elements with the
siderophores of environmental microbes. With regards to side-
romycins, many of the early discoveries of natural sideromy-
cins require follow-up investigations. Such eﬀorts have largely
been eclipsed by initiatives to produce synthetic siderophore-
drug conjugates to combat bacterial pathogens, including anti-
biotic-resistant strains. Although it lay outside the scope of
this Perspective, we anticipate increased investigation into the
use of siderophores as medicines to treat various human dis-
eases. For instance, although DFOB is well-established for the
treatment of iron-overload in conditions such as thalassemia
and myelodysplastic syndrome, its use to treat other diseases,
such as malaria, remains contentious.244
In addition to more focused investigations on the inter-
actions of siderophores and siderophore-producing bacteria
with non-iron metals, we expect that increased attention will
be paid to larger mechanistic questions related to the means
by which organisms employ siderophores for non-classical
purposes without interference from the Fe-transport functions
of these molecules. Also, better criteria will need to be estab-
lished to delineate the diﬀerence between situations in which
a siderophore simply exhibits the ability to interact with other
metals and those situations in which these interactions are
biologically relevant.
In closing, the chemistry of siderophores is vast, even when
restricted to iron transport. The wide expanse of chemical
space representing the interactions of siderophores with non-
iron elements is certain to contain a wealth of discoveries in
chemistry and biology. We anticipate that a great increase in
the number of non-classical functions attributed to these
molecules is forthcoming as we come to better understand the
subtleties of siderophore chemistry.
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